These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3570468)
1. Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Yamamoto Y; Klein TW; Newton CA; Widen R; Friedman H Infect Immun; 1987 Jun; 55(6):1369-74. PubMed ID: 3570468 [TBL] [Abstract][Full Text] [Related]
2. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection. Yamamoto Y; Klein TW; Newton C; Friedman H J Immunol; 1992 Jan; 148(2):584-9. PubMed ID: 1729375 [TBL] [Abstract][Full Text] [Related]
3. Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Yamamoto Y; Klein TW; Newton CA; Widen R; Friedman H Infect Immun; 1988 Feb; 56(2):370-5. PubMed ID: 3257460 [TBL] [Abstract][Full Text] [Related]
4. Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs. Nikaido Y; Yoshida S; Goto Y; Mizuguchi Y; Kuroiwa A Infect Immun; 1989 Nov; 57(11):3458-65. PubMed ID: 2807531 [TBL] [Abstract][Full Text] [Related]
5. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. Nash TW; Libby DM; Horwitz MA J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140 [TBL] [Abstract][Full Text] [Related]
6. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. Blander SJ; Szeto L; Shuman HA; Horwitz MA J Clin Invest; 1990 Sep; 86(3):817-24. PubMed ID: 2203824 [TBL] [Abstract][Full Text] [Related]
7. [Models for the study of the toxic action of Legionella pneumophila]. TartakovskiÄ IS; Barkhatova OI; ProzorovskiÄ EV Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):52-5. PubMed ID: 6741365 [TBL] [Abstract][Full Text] [Related]
8. Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs. Yoshida S; Mizuguchi Y; Nikaido Y; Mitsuyama M; Nomoto K Infect Immun; 1987 Oct; 55(10):2477-82. PubMed ID: 3308708 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [TBL] [Abstract][Full Text] [Related]
10. Temperature effects on Legionella pneumophila killing by and multiplication in phagocytes of guinea pigs. Miyamoto H; Ogawa M; Maruta K; Nikaido Y; Yamamoto C; Taniguchi H; Yoshida S Microbiol Immunol; 1995; 39(9):647-54. PubMed ID: 8577277 [TBL] [Abstract][Full Text] [Related]
11. Differential morphologic and metabolic alterations in permissive versus nonpermissive murine macrophages infected with Legionella pneumophila. Yamamoto Y; Klein TW; Brown K; Friedman H Infect Immun; 1992 Aug; 60(8):3231-7. PubMed ID: 1322369 [TBL] [Abstract][Full Text] [Related]
12. Multiplication of Legionella pneumophila Philadelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals. Yoshida S; Mizuguchi Y Can J Microbiol; 1986 May; 32(5):438-42. PubMed ID: 3719461 [TBL] [Abstract][Full Text] [Related]
13. Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors. Husmann LK; Johnson W Infect Immun; 1992 Dec; 60(12):5212-8. PubMed ID: 1452353 [TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility and caspase activation in mouse and human macrophages are distinct for Legionella longbeachae and L. pneumophila. Asare R; Santic M; Gobin I; Doric M; Suttles J; Graham JE; Price CD; Abu Kwaik Y Infect Immun; 2007 Apr; 75(4):1933-45. PubMed ID: 17261610 [TBL] [Abstract][Full Text] [Related]
16. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model. Moffat JF; Edelstein PH; Regula DP; Cirillo JD; Tompkins LS Mol Microbiol; 1994 Jun; 12(5):693-705. PubMed ID: 8052122 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Blander SJ; Horwitz MA J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324 [TBL] [Abstract][Full Text] [Related]
18. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH; Shinzato T; Edelstein MA J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [TBL] [Abstract][Full Text] [Related]
19. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. Breiman RF; Horwitz MA J Exp Med; 1987 Mar; 165(3):799-811. PubMed ID: 3819647 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. Blander SJ; Horwitz MA J Clin Invest; 1991 Mar; 87(3):1054-9. PubMed ID: 1999485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]